eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant
The IND clearance supports a Phase 1/2/3 study to determine the safety and efficacy of their porcine-derived kidney in patients with dialysis-dependent ESKD, over the age of 50, who are currently on a transplant waitlist.
Read the full article » | Posted 09-15-2025
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025
- Fresenius Shares 5 Ways Artificial intelligence is Helping Dialysis Care Posted 08-21-2025